ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #7,692Hybrid

Melanoma Research

Acronym:mr
•
Abbreviation (ISO):MELANOMA RES
•
Identifier (ISSN):0960-8931(Print)/1473-5636(Online)
•
Publisher:Lippincott Williams and Wilkins Ltd.
Clarivate IF (2026)
1.8↓ -0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Melanoma Research

WoS Q3
12452.7520203.620213.220222.220231.520241.920251.82026
Annual Impact Factor Metric
Current (2026):1.8
Scopus SJR & RankScopus Q2
0.74
#7,692

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
86

86 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate6.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
79articles/year
22.34% Gold OA•88.89% Original Research

Aims & Scope

​​​​​​Melanoma Research is a well established international forum for the dissemination of new findings relating to melanoma. The aim of the Journal is to promote the level of informational exchange between those engaged in the field. Melanoma Research aims to encourage an informed and balanced view of experimental and clinical research and extend and stimulate communication and exchange of knowledge between investigators with differing areas of expertise. This will foster the development of translational research. The reporting of new clinical results and the effect and toxicity of new therapeutic agents and immunotherapy will be given emphasis by rapid publication of Short Communications. ​Thus, Melanoma Research seeks to present a coherent and up-to-date account of all aspects of investigations pertinent to melanoma. Consequently the scope of the Journal is broad, embracing the entire range of studies from fundamental and applied research in such subject areas as genetics, molecular biology, biochemistry, cell biology, photobiology, pathology, immunology, and advances in clinical oncology influencing the prevention, diagnosis and treatment of melanoma.

Topics Covered (Recognized by AI)
Medicine93.8%Biology89.8%Genetics85.2%Cancer research75.3%Melanoma70.8%Internal medicine65.3%Chemistry46.5%Biochemistry38.7%Pathology38.4%Cancer35.3%Immunology32%Dermatology28.8%Surgery26.1%Oncology23.7%Physics22.3%Gene20.6%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

DERMATOLOGY

Q3
Rank61/99
IndexSCIE
JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q3
Rank136/191
IndexSCIE
JCRSCIE2026

ONCOLOGY

Q4
Rank264/333
IndexSCIE
JCISCIE2026

DERMATOLOGY

Q3
Rank64/99
IndexSCIE
JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q3
Rank110/191
IndexSCIE
JCISCIE2026

ONCOLOGY

Q3
Rank216/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.8
Articles / Year61
Total Citations11
2025
IF1.9
Articles / Year56
Total Citations69
2024
IF1.5
Articles / Year69
Total Citations262
2023
IF2.2
Articles / Year78
Total Citations398
2022
IF3.199
Articles / Year74
Total Citations521

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,692Scopus Q2SCImago Profile
Scopus Coverage:1991-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q2
0.74

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.73

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,133 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations371
3-Year Documents217
Citable Documents197

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate52.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

DermatologyQ2
OncologyQ2
Cancer ResearchQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 6.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Melanoma Research (acronym: mr, abbr: MELANOMA RES, ISSN: 0960-8931) is a peer-reviewed international scholarly journal in the field of Medicine, published by Lippincott Williams and Wilkins Ltd. in United States since 1991. The periodical holds a Journal Impact Factor (JIF) of 1.80, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.740 (Q2), an H-index of 86.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 79 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,133 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Lippincott Williams and Wilkins Ltd.
Publication Language
English
Frequency
Bimonthly
Founding Year
1991
Indexing & Databases
SCIEScopusPubMed
Editorial Address
LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 5ff0eb5d-4551-484b-ba1f-e9d2c1aef364
Database Updated: 2026-09-29